Johnson & Johnson recalls 200,000 bottles of ibuprofen for infants and young children, the product was not sold to China
Beijing Times (Reporter Ping Yifan) Johnson & Johnson has begun recalling 200,000 bottles of infant ibuprofen in the United States because of faulty manufacturing identification, the Food and Drug Administration (FDA) said on its website yesterday. The particles may contain tiny plastic particles that pose a potential danger.
The recall will involve three batches of ibuprofen's original berry flavored suspension drops, which are used to reduce fever and relieve pain in infants 2 years of age or younger. The maker of the drug, McNeil, a unit of Johnson & Johnson, said it found tiny plastic particles in a batch it was manufacturing that came from a third-party supplier of ibuprofen ingredients. Consumers are advised to stop using the product immediately due to the potential risk. The company has now initiated a voluntary recall process.
According to the reporter, Johnson & Johnson's ibuprofen drug is also sold in China. Shanghai Johnson & Johnson Pharmaceutical Co., Ltd. production of Meilin ibuprofen suspension drops, 6-36 months of infants and toddlers caused by fever and cold headache, sore throat and other symptoms. Lu Jing, director of government affairs and media at Shanghai Johnson & Johnson Pharmaceutical, told reporters that the product in question was not sold to the Chinese mainland or Hong Kong, so the recall does not involve China.